Loading
PM
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) Stock: price and insider trades · Canada
Profound Medical Corp. (formerly Mira IV Acquisition Corp.): what insiders have been doing
Every trade that managers of Profound Medical Corp. (formerly Mira IV Acquisition Corp.) disclose to SEDI is tracked on this page. Profound Medical Corp. (formerly Mira IV Acquisition Corp.) has had no insider filing for more than a year; the last one goes back to 20 December 2022.
Our records for Profound Medical Corp. (formerly Mira IV Acquisition Corp.) go back to 2016, with 42 purchases and 3 sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
73
Thresholds
n/a
Buy Volume
€2M
42 ops. · all time
Sell Volume
€3M
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 20 December 2022
Declarations73 total
13,000 shares@ CA$7.8066Common SharesTSXSEDI:4047767
Canonical exit: 20 Mar 2023 (T+90)
5,000 shares@ CA$5.5927.6% of flowCommon SharesTSXSEDI:4001384
Canonical exit: 6 Dec 2022 (T+90)
2,500 shares@ CA$7.5625.1% of flowCommon SharesTSXSEDI:3961295
Canonical exit: 12 Sept 2022 (T+90)
6,762 shares@ CA$9.08432.3% of flowCommon SharesTSXSEDI:3954105
Canonical exit: 29 Aug 2022 (T+90)
500 shares@ CA$9.222.4% of flowCommon SharesTSXSEDI:3954106
Canonical exit: 30 Aug 2022 (T+90)
3,000 shares@ CA$8.928514.2% of flowCommon SharesTSXSEDI:3954107
Canonical exit: 30 Aug 2022 (T+90)
538 shares@ CA$9.48322.7% of flowCommon SharesTSXSEDI:3953975
Canonical exit: 31 Aug 2022 (T+90)
1,000 shares@ CA$6.550.3% of flowCommon SharesTSXSEDI:3949949
Canonical exit: 22 Aug 2022 (T+90)
2,500 shares@ CA$6.900.8% of flowCommon SharesTSXSEDI:3948919
Canonical exit: 18 Aug 2022 (T+90)
1,735 shares@ CA$8.6235.2% of flowCommon SharesTSXSEDI:3948458
Canonical exit: 18 Aug 2022 (T+90)
Common SharesTSXSEDI:3948017
600 shares@ CA$8.906.9% of flowCommon SharesTSXSEDI:3948019
Canonical exit: 11 Aug 2022 (T+90)
2,400 shares@ CA$8.6826.8% of flowCommon SharesTSXSEDI:3948412
Canonical exit: 18 Aug 2022 (T+90)
3,000 shares@ CA$18.73266.4% of flowCommon SharesTSXSEDI:3948018
Canonical exit: 18 Aug 2021 (T+90)
4,000 shares@ CA$8.9514.9% of flowCommon SharesTSXSEDI:3946689
Canonical exit: 16 Aug 2022 (T+90)
30,000 shares@ CA$6.92359.9% of flowCommon SharesTSXSEDI:3945210
Canonical exit: 11 Aug 2022 (T+90)
30,516 shares@ CA$6.65489.7% of flowCommon SharesTSXSEDI:3944538
Canonical exit: 10 Aug 2022 (T+90)
8,000 shares@ CA$7.0657100.0% of flowCommon SharesTSXSEDI:3944536
Canonical exit: 10 Aug 2022 (T+90)
50,000 shares@ CA$7.0554.6% of flowCommon SharesTSXSEDI:3944080
Canonical exit: 10 Aug 2022 (T+90)
45,584 shares@ CA$8.104821.5% of flowCommon SharesTSXSEDI:3901669
Canonical exit: 6 Jun 2022 (T+90)
15,000 shares@ CA$8.537.4% of flowCommon SharesTSXSEDI:3901913
Canonical exit: 7 Jun 2022 (T+90)
8,100 shares@ CA$12.393534.2% of flowCommon SharesTSXSEDI:3828154
Canonical exit: 7 Feb 2022 (T+90)
535 shares@ CA$18.7032.9% of flowCommon SharesTSXSEDI:3800229
Canonical exit: 6 Dec 2021 (T+90)
32,608 shares@ CA$9.2026.9% of flowCommon SharesTSXSEDI:3796353
Common SharesTSXSEDI:3790344
25 of 73 declarations
About Profound Medical Corp. (formerly Mira IV Acquisition Corp.)
Profound Medical Corp. is a medical technology company that develops innovative solutions for the treatment of prostate cancer. It was formerly known as Mira IV Acquisition Corp.
